Yüklüyor......

Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial

BACKGROUND: Vascular dementia (VaD) is the 2nd most common subtype of dementia after Alzheimer disease. Currently, there are no medications approved for treating patients with VaD. Tianmabianchunzhigan (TMBCZG) tablet is an active ingredient extracted from Gastrodia that has been reported to improve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Tian, Jinzhou, Shi, Jing, Wei, Mingqing, Li, Ting, Ni, Jingnian, Zhang, Xuekai, Zhang, Meng, Li, Yang, Wang, Yongyan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319825/
https://ncbi.nlm.nih.gov/pubmed/30572524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013760
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!